The peptide “YLYDGRIFI” was capable of upregulating IFN-γ and IL-17A production from the PBMCs of a subgroup of anti-Sm-positive SLE patients in an HLA-DR-dependent manner. Here, IFNG is linked to systemic lupus erythematosus.